Krystal Biotech
KRYS
KRYS
57 hedge funds and large institutions have $223M invested in Krystal Biotech in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+12
Holders Change %
+26.67%
% of All Funds
1.24%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
19
Reduced
16
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$4.22M |
| 2 |
Millennium Management
New York
|
+$2.93M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.77M |
| 4 |
O
OrbiMed
New York
|
+$1.95M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.6M |
Top Sellers
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$2.96M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$979K |
| 3 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$650K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$400K |
| 5 |
Renaissance Technologies
New York
|
-$365K |
